Inventiva (IVEVF) Research & Development (2019 - 2021)
Inventiva (IVEVF) posted Research & Development of -$14.3 million for Q2 2021, down 65.27% on a QoQ basis from -$8.7 million in Q1 2021, and down 99.91% year-over-year from -$15.3 billion in Q2 2020.
Analysis
Inventiva (IVEVF) Research & Development (2019 - 2021) Analysis & Trends
Inventiva has reported Research & Development for 3 years, with the latest figure at -$14.3 million in Q2 2021.
- On a quarterly basis, Research & Development fell 99.91% year-over-year to -$14.3 million in Q2 2021; TTM through Jun 2021 was -$58.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$101.3 million, down 4.33% from the prior year.
- Research & Development was -$14.3 million for Q2 2021 at Inventiva, down from -$8.7 million in the prior quarter.
- The five-year high for Research & Development was -$6.7 million in Q1 2020, with the low at -$37.4 million in Q4 2019.
- Average Research & Development over 3 years is -$17.1 million, with a median of -$11.5 million recorded in 2021.
- The sharpest annual moves came in 2020 and 2021: Research & Development gained 24.4% in 2020, then tumbled 99.91% in 2021.
- Over 3 years, Research & Development stood at -$37.4 million in 2019, then climbed by 24.4% to -$28.3 million in 2020, then jumped by 49.27% to -$14.3 million in 2021.
- The last three Research & Development figures came in at -$14.3 million (Q2 2021), -$8.7 million (Q1 2021), and -$28.3 million (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 2.81 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -2.60 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | 394.92 Mn |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 516.95 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 146.30 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -14.35 Mn |
| Mar 31, 2021 | -8.68 Mn |
| Dec 31, 2020 | -28.28 Mn |
| Jun 30, 2020 | -7.18 Mn |
| Mar 31, 2020 | -6.69 Mn |
| Dec 31, 2019 | -37.40 Mn |